-
Study Shows Tiny ‘Twisters’ Move Cytoplasm Within Cells
Investigators at Northwestern Medicine and the Flatiron Institute have characterized how developing cells reorganize their cytoplasm as part of their growth, according to a study published in Nature Physics, a discovery which furthers the field’s understanding of basic cellular processes at the earliest stages of development.
-
Neuronal Diversity Impacts the Brain’s Information Processing
Northwestern Medicine investigators have revealed new insights into the impact of neuronal structural diversity on neural computation, the basis of brain function, according to a recent study published in the Proceedings of the National Academy of Sciences.
-
Rethinking the Burden of Cancer Treatments’ Side Effects
Even mild and moderate side effects can contribute to patients with cancer discontinuing their treatment, according to an analysis recently published in the Journal of Clinical Oncology.
-
Genes May Predict Treatment Resistance in Prostate Cancer
Increased expression of specific genes in prostate cancer patients may predict whether or not the cancer will respond well to hormone therapy, according to a new study published in Nature Communications.
-
Immune Genes Are Altered in Alzheimer’s Patients’ Blood
A new study has found the immune system in the blood of Alzheimer’s patients is epigenetically altered, and many of these altered genes are the same ones that increase an individual’s risk for Alzheimer’s.
-
Shedding Light on the Synaptic Complexities of Vision
An individual retinal cell can output more than one unique signal, according to a Northwestern Medicine study published in Nature Communications, a finding which sheds new light on the complexities of how vision functions in mammals.
-
Human Longevity Lab Will Study Methods to Slow or Reverse Aging
Northwestern Medicine has launched the Human Longevity Laboratory, a longitudinal, cross-sectional study that will investigate the relationship between chronological age and biological age and validate interventions that may reverse or slow down the processes of aging.
-
How Research is Changing the Conversation about Obesity
In the last several years, anti-obesity medications have made an impression through wide media coverage and interest in their effectiveness. Feinberg investigators have been leading research on these drugs for the treatment of obesity and advocating for access to these medications for the patients who need it most.
-
Feinberg Faculty Inducted into American Society for Clinical Investigation
Four Feinberg faculty have been inducted into the American Society for Clinical Investigation (ASCI) and three additional Feinberg faculty have been honored with the ASCI Young Physician-Scientist Award.
-
Wakschlag Honored With 2024 Paula H. Stern Award
Lauren Wakschlag, PhD, professor of Medical Social Sciences, Pediatrics and Psychiatry and Behavioral Sciences, has been awarded the Paula H. Stern Award for Outstanding Women in Science and Medicine by the Northwestern Medical Women Faculty Organization.
-
Using Cancer’s Strength to Fight Against It
In findings published in Nature, scientists may have found a way around the limitations of engineered T-cells by borrowing a few tricks from cancer itself.
-
Study Identifies Molecular Mechanisms of Rare Neurodevelopmental Disorder
Investigators from the laboratory of Alicia Guemez-Gamboa, PhD, assistant professor of Neuroscience, have discovered new molecular mechanisms of PACS1 syndrome, a rare neurodevelopmental disorder, according to findings published in Nature Communications.
-
Survey Shows Leadership and Peer Support Essential for Resident Success
Residents are more likely to flourish in their training programs and daily lives when peer-support is strong and leadership prioritizes residents’ wellbeing, according to results from a multi-institutional survey published in Annals of Internal Medicine.
-
Nobel Laureate and World-Renowned Geneticist to Speak at 2024 Commencement
Michael S. Brown, MD, director of the Jonsson Center for Molecular Genetics and Regental Professor at the University of Texas, Southwestern Medical School, will address graduates and their guests at Feinberg’s 165th commencement ceremony on Monday, May 13.
-
Investigating Methods for Preventing Pancreatitis after Endoscopy
Anti-inflammatory drugs alone are not sufficient to prevent pancreas inflammation following a common endoscopic procedure, according to a study recently published in The Lancet.
-
Transcription Factors Influence Insulin-Producing Beta Cells
A recent study from the laboratory of Joseph Bass, MD, PhD, has revealed how transcription factors within individual cells influence the identity and function of insulin-producing beta cells in the pancreas, according to findings published in Cell Metabolism.
-
COVID-19 Vaccines Highly Effective for Children During Delta and Omicron Waves, Study Finds
The Pfizer BioNTech BNT162b2 vaccine was highly effective in preventing severe COVID-19 infections in children and adolescents during the Delta and Omicron variants, according to a large, national study recently published in the Annals of Internal Medicine.
-
As Patients Live Longer, New Criteria Needed for Prostate Cancer Trials
A lack of cancer progression could be used as a surrogate for overall survival in newly metastatic prostate cancer clinical trials, according to a new meta-analysis published in the Journal of Clinical Oncology.
-
New Anti-Blood Clotting Drug May Lower Risk of Recurrent Strokes
An experimental drug designed to block blood-clotting proteins may slightly lower the risk of recurrent strokes, according to a dose-finding trial published in The Lancet Neurology.
-
Decorated Nanoparticles Prevent Allergic Reactions
Northwestern University scientists have developed the first selective nanoparticle therapy to prevent allergic reactions, which can range in severity from itchy hives and watery eyes to trouble breathing and even death.
